Cargando…

Isoniazid (INH) mono-resistance and tuberculosis (TB) treatment success: analysis of European surveillance data, 2002 to 2014

Introduction: Isoniazid (INH) is an essential drug for tuberculosis (TB) treatment. Resistance to INH may increase the likelihood of negative treatment outcome. Aim: We aimed to determine the impact of INH mono-resistance on TB treatment outcome in the European Union/European Economic Area and to id...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karo, Basel, Kohlenberg, Anke, Hollo, Vahur, Duarte, Raquel, Fiebig, Lena, Jackson, Sarah, Kearns, Cathriona, Ködmön, Csaba, Korzeniewska-Kosela, Maria, Papaventsis, Dimitrios, Solovic, Ivan, van Soolingen, Dick, van der Werf, Marieke J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440580/ https://www.ncbi.nlm.nih.gov/pubmed/30914081 http://dx.doi.org/10.2807/1560-7917.ES.2019.24.12.1800392

Ejemplares similares

Eligibility for shorter treatment of multidrug-resistant tuberculosis in the European Union
por: van der Werf, Marieke J., et al.
Publicado: (2017)

Determinants of site of tuberculosis disease: An analysis of European surveillance data from 2003 to 2014
por: Sotgiu, Giovanni, et al.
Publicado: (2017)

Tuberculosis and HIV coinfection in Europe: looking at one reality from two angles
por: van der Werf, Marieke J., et al.
Publicado: (2016)

Pattern of InhA and KatG mutations in isoniazid monoresistant Mycobacterium tuberculosis isolates
por: Charan, Ashok Singh, et al.
Publicado: (2020)

Clarity with INHindsight: High-Dose Isoniazid for Drug-Resistant Tuberculosis with inhA Mutations
por: Wasserman, Sean, et al.
Publicado: (2020)

A study of the effect of Nigella sativa (Black seeds) in isoniazid (INH)-induced hepatotoxicity in rabbits
por: Hassan, Anwar S., et al.
Publicado: (2012)

Molecular Dynamics Assisted Mechanistic Study of Isoniazid-Resistance against Mycobacterium tuberculosis InhA
por: Kumar, Vivek, et al.
Publicado: (2015)

Inducing vulnerability to InhA inhibition restores isoniazid susceptibility in drug resistant Mycobacterium tuberculosis
por: Harrison, Gregory A., et al.
Publicado: (2023)

Is tuberculosis crossing borders at the Eastern boundary of the European Union?
por: van der Werf, Marieke J., et al.
Publicado: (2013)

Tuberculosis notification rate decreases faster in residents of native origin than in residents of foreign origin in the EU/EEA, 2010 to 2015
por: Hollo, V, et al.
Publicado: (2017)

The relation of isoniazid (INH) and allied compounds to carcinogenesis in some species of small laboratory animals: a review.
por: Biancifiori, C., et al.
Publicado: (1966)

Minor Contribution of inhA-15 Mutations to the Rapid Detection of Isoniazid Resistance in Mycobacterium Tuberculosis Isolates
por: Abkar, Roya, et al.
Publicado: (2016)

Detection of KatG/inhA Mutation to Guide Isoniazid and Ethionamide Use for Drug-resistant Tuberculosis
por: Namburete, Evangelina
Publicado: (2017)

Inventory study of non-tuberculous mycobacteria in the European Union
por: van der Werf, Marieke J, et al.
Publicado: (2014)

Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic
por: Isakova, Jainagul, et al.
Publicado: (2018)

Intravaginal Isoniazid (INH) and Sublingual Misoprostol Versus Sublingual Misoprostol Alone for First-Trimester Induced Abortion: A Randomized Controlled Trial
por: Haghighi, Ladan, et al.
Publicado: (2023)

Prevalence of latent tuberculosis infection among patients with interstitial lung disease requiring immunosuppression
por: Kempisty, Anna, et al.
Publicado: (2022)

Molecular and genomic typing for tuberculosis surveillance: A survey study in 26 European countries
por: Andrés, Marta, et al.
Publicado: (2019)

Characteristics and Treatment Outcomes of Isoniazid Mono-Resistant Tuberculosis: A Retrospective Study
por: Kwak, Se Hyun, et al.
Publicado: (2020)

Molecular Characterization of katG and inhA Mutations by Genotype MTBDRplus Line Probe Assay To Guide Isoniazid and Ethionamide Use for Drug-Resistant Tuberculosis
por: Ranjan, K. P., et al.
Publicado: (2023)

Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin- Mono-Resistant Pulmonary Tuberculosis in Lima, Peru
por: Villegas, Leonela, et al.
Publicado: (2016)

The impact of comorbidities on tuberculosis treatment outcomes in Poland: a national cohort study
por: Nowiński, Adam, et al.
Publicado: (2023)

Resistance patterns and transmission of mono- and polyresistant TB: clinical impact of WGS
por: Dohál, Matúš, et al.
Publicado: (2023)

Impact of the COVID-19 pandemic on tuberculosis laboratory services in Europe
por: Nikolayevskyy, Vladyslav, et al.
Publicado: (2021)

A high‐throughput LC–MS/MS method for simultaneous determination of isoniazid, ethambutol and pyrazinamide in human plasma
por: Pršo, Kristián, et al.
Publicado: (2022)

Tuberculosis among people living with HIV/AIDS in the German ClinSurv HIV Cohort: long-term incidence and risk factors
por: Karo, Basel, et al.
Publicado: (2014)

Expression of INHβA and INHβB proteins in porcine oocytes cultured in vitro is dependent on the follicle size
por: Kempisty, Bartosz, et al.
Publicado: (2015)

SERPING1 Variants and C1-INH Biological Function: A Close Relationship With C1-INH-HAE
por: Drouet, Christian, et al.
Publicado: (2022)

Epidemiology of Mycobacterium bovis Disease in Humans in England, Wales, and Northern Ireland, 2002–2014
por: Davidson, Jennifer A., et al.
Publicado: (2017)

Pre-Existing Isoniazid Resistance, but Not the Genotype of Mycobacterium Tuberculosis Drives Rifampicin Resistance Codon Preference in Vitro
por: Bergval, Indra, et al.
Publicado: (2012)

Whole-Genome Sequencing as Tool for Investigating International Tuberculosis Outbreaks: A Systematic Review
por: van der Werf, Marieke J., et al.
Publicado: (2019)

Current state of national TB laboratory networks in Europe: achievements and challenges
por: Klaos, K., et al.
Publicado: (2022)

Evaluation of a new automated Abbott RealTime MTB RIF/INH assay for qualitative detection of rifampicin/isoniazid resistance in pulmonary and extra-pulmonary clinical samples of Mycobacterium tuberculosis
por: Ruiz, Pilar, et al.
Publicado: (2017)

Should treatment of low-level mono-resistant tuberculosis be different?
por: Gopie, F.A., et al.
Publicado: (2021)

Experiences from 4 Years of Organization of an External Quality Assessment for Mycobacterium tuberculosis Whole-Genome Sequencing in the European Union/European Economic Area
por: Anthony, R. M., et al.
Publicado: (2022)

Incidence, treatment, and outcomes of isoniazid mono-resistant Mycobacterium tuberculosis infections in Alberta, Canada from 2007-2017
por: Edwards, Brett D., et al.
Publicado: (2020)

Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistance
por: Park, Mirae, et al.
Publicado: (2022)

Effectiveness and safety of Levofloxacin containing regimen in the treatment of Isoniazid mono-resistant pulmonary Tuberculosis: a systematic review
por: Inbaraj, Leeberk Raja, et al.
Publicado: (2023)

Primary Isoniazid Mono-Resistant Extrapulmonary Tuberculosis Presenting as Cervical Lymphadenitis: The World’s First Case of Its Type
por: Yadav, Sankalp
Publicado: (2023)

The impact of combined gene mutations in inhA and ahpC genes on high levels of isoniazid resistance amongst katG non-315 in multidrug-resistant tuberculosis isolates from China
por: Liu, Liguo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_uqpm8dvkcc37q26sfer2263bq7